Biopesticides are needed for control of endemic and invasive pests impacting New Zealand's primary sectors including pests that are emerging as a result of climate change and farming 
Introduction
New Zealand's economy and reputation are closely linked to its agricultural and natural landscapes, with 85% of overseas earnings derived from agriculture, forestry and tourism.
The productive capacity of the pastoral, horticultural, arable and forestry sectors relies on numerous introduced plant species. These exotic plant species are subject to endemic pest species that have adapted to feeding on introduced crops and a wide range of invasive species that have established successfully in New Zealand.
New Zealand is very prone to pest incursions (e.g. O'Callaghan et al. 2002 , Goldson et al. 2016 ) which have sometimes led to devastating pest outbreaks. In some cases, the introduced species are not pests in their native ranges, for example Sitona obsoletus (= S. lepidus), the clover root weevil, which is native to Europe, has adversely affected clover based pastures in New Zealand since its introduction in the 1990s (Gerard et al. 2007 ).
External factors, such as globalisation and free trade, mean that the rate of pest incursions is only likely to increase and place further pressure on existing methods for pest control (Kriticos et al. 2005) . In addition, some endemic pests are becoming more problematic as a result of intensification of farming systems, land use changes and changing climatic conditions. For example, populations of the endemic pasture pest the New Zealand grass grub (Costelytra zealandica) rapidly increased to economically damaging levels following installation of irrigation schemes on previous dryland pasture . The distribution of the exotic pest South African black beetle Heteronychus arator is also likely to increase as a result of hotter summers in New Zealand (Bell et al. 2011) .
To reduce the impact of insect pests, pastoral farmers and horticultural and arable growers have relied heavily on pesticides, biological control and, in some situations, integrated pest management (IPM) systems (Manktelow et al. 2005) . For some pests, such as several weevil pests, implementation of biological control strategies based on carefully selected parasitoid wasps have been extremely successful (Goldson et al. 2004 , Gerard et al. 2007 ). Similarly, long-standing IPM systems underpin New Zealand's highly competitive apple and kiwifruit export industries (e.g. Stephens and McKenna 1999) . Despite these approaches, there is still considerable reliance on synthetic pesticides in New Zealand. A review in 2004 found that pesticide imports constituted approximately 1% of the value of New Zealand's agricultural exports at that time, which was valued at US$8 billion (Manktelow et al. 2005) . However, several synthetic pesticides have been banned recently (e.g. fenitrothion or phorate; Environmental Protection Agency 2017) or will be deregistered in the future (e.g. diazinon will be restricted for pasture use by 2028; Environmental Protection Agency 2016). The threat of further de-registration of pesticides, declining social acceptability of these products, increasing incidence of resistance, and ongoing imposition of phytosanitary requirements by off-shore markets is driving increased interest in alternative solutions, in particular microbial biopesticides (Glare et al. 2012 ). An additional driver in New Zealand is the high likelihood of new pest incursions which further highlights the need for safe control options as incursions most often occur around ports and in heavily populated areas. Microbial biopesticides are also an attractive option with their low non-target impacts and they fit well with the many finely tuned IPM systems mentioned above that underpin several key export crop production systems. (Jackson et al. 2010 ). There are no locally produced products based on Bt as it has been relatively easy to import well evaluated Bt products from overseas and Bt is ubiquitous in its distribution. The major use of Bt-based products has been in apples and kiwifruit, where they form part of ongoing IPM programmes. New Zealand's kiwifruit production systems remain based on the "Kiwigreen" IPM system developed in the 1990s, with late season leafrollers managed using Bt (Stephens and McKenna 1999, Aitken et al. 2004) . 
Importation of biopesticides containing microorganisms not known to be present in New
Zealand requires approval from the Environmental Protection Agency (EPA) and Ministry for Primary Industries (MPI). The New Organisms Act of 1998 determined that an organism not recorded as present in the country before 1996 requires specific clearance from the EPA before it can be released in New Zealand. Recent efforts to import the nematode Phasmarhabditis hermaphrodita for slug control required a countrywide survey to demonstrate that the nematode was naturally present in New Zealand (Wilson et al. 2016, reviewed below) . The effort and costs required to demonstrate presence in New Zealand will only be justified where there is sufficient market size and high demand for the product.
There are obvious benefits in importing commercially available biopesticides from off-shore.
The research and development and safety testing has already been completed and effective formulations developed. New Zealand regulators are generally accepting of EU and US EPA data packages and this can reduce the costs of registration in New Zealand significantly.
However, further work may be needed to ensure that the imported products will be effective and safe under New Zealand environmental conditions and within the country's cropping systems. This will require research within New Zealand, testing imported products against endemic non-target organisms under local conditions. Generally such work is conducted by independent researchers for the importing companies. It may be necessary to evaluate activity against a range of New Zealand-specific non-target endemic and/or iconic species which can be problematic if laboratory bioassay techniques have not already been developed.
Examples of products developed in New Zealand

Bioshield® (previously Invade®)
One of the more interesting biopesticides registered in New Zealand is based on the indigenous insect pathogenic bacterium Serratia entomophila (recently transferred to the Yersinaceae, Adeolu et al. 2016 ). This bacterium was discovered as a causal agent of "amber disease" in the New Zealand grass grub, the most damaging scarab pest of pastures in New
Zealand (Trough et al. 1982) , and was developed into a biopesticide sold as Invade™ (Jackson et al. 1992) . However, while the high host specificity of S. entomophila means the product has no non-target effects, it also limits the market size for Invade. In addition, this product was initially produced as a liquid formulation that required refrigerated storage and distribution. These limitations were overcome with the development of a stable granular formulation of this non spore-forming bacterium -BioShield® -based on biopolymer technology (Johnson et al. 2001; Glare et al. 2016) . Bioshield Grass Grub remains one of the very few biopesticide products worldwide to be based on a non-sporeforming bacterium.
Various formulations of the BioShield product have performed well in the field (Townsend et al. 2004; Zydenbos et al. 2016 ). However, despite C. zealandica being a widespread pest in New Zealand, the small market size has meant that the product has not been continuously produced and marketed to farmers. At the time of writing (2017) , a New
Zealand company Biostart has registered both a liquid and granular formulation as Bioshield Grass Grub®. The liquid formulation has Biogro (organic) certification and has attracted interest as a control measure for grass grub in vineyards. Grass grub remains a significant problem not only in pastures but also in a range of arable and horticultural crops and Bioshield Grass Grub® is expected to play a key role in management of this pest following the anticipated withdrawal of diazinon (Environmental Protection Agency 2017). whiteflies and thrips. The products were sold for around 4-5 years and were successfully used on over 1,000 hectares (Stephen Ford, pers. comm.) but production has ceased in recent years as the company has looked to license the technologies internationally.
Beaublast®, based on
Fungal endophytes
One of the success stories for biopesticides (using the definition of biopesticides which includes endophytes; Glare et al. 2012) in New Zealand is not a registered microbial product, but carefully selected plant-fungal endophyte combinations, sold as fungus-colonised seed, and covered by plant variety rights protection. The ability of naturally occurring endophytes from the genera Epichloë (Ascomycetes; Clavicipitaceae) to provide resistance to pests and diseases of grasses has been developed into a thriving industry, both in New Zealand and internationally (Johnson et al. 2013) . Some asexual Epichloë species, such as E. festucae var.
lolii that infects perennial ryegrass and E. coenophiala in tall fescue, were commercialised in New Zealand from the early 2000s, and now almost all ryegrass seed sold contains a beneficial endophyte. One of the main companies involved is the New Zealand company, Grasslanz Technology Ltd (Johnson et al. 2013 (Card et al. 2016 ).
Registration process in New Zealand
In New Zealand registration of pesticides, including those based on microorganisms, is through the ACVM, a part of New Zealand's Ministry for Primary Industries. If the organism is new to New Zealand (including isolated in New Zealand but not previously documented), or modified in any way, approvals are also needed from the EPA. An overview of the registration process is shown in Figure 1 .
Guidelines for the registration of biopesticides -referred to as "Microbial Agricultural The micro-organisms that constitute the active ingredients in the formulation, referred to as microbial active ingredients (MAIs), are defined as any micro-organism, genetically modified organism or naturally occurring mutants of micro-organisms, intended for sale to manage pests. This includes whole organisms (viable or non-viable), organelles, metabolites, spores or occlusion bodies used for the control or management of invertebrate pests, weeds or microbial pathogens of crops.
As with most countries, application for registration requires technical data and/or scientifically sound arguments to support the application. The ACVM guidelines (2016) list the following data requirements:
1. Quality, purity and stability of the product; 2. Product's efficacy for all label claims; 3. Crop safety 4. Maximum residue levels (MRLs), including the establishment of an MRL resulting from trial work that adheres to the residue guidelines or an argument or data to show that the MAI fits an existing exception in the MRL Notice (Schedule 2) or to promulgate a new exception;
5. Any possible impact on trade resulting from the use of the MAC in crops, and/or carry over residues as a result feed crops in food-producing animals, if applicable.
Note that these changes have occurred within wider context of significant proposed revision of the Hazardous Substances regulation by MPI.
Future directions
Given the limited size of the New Zealand market, to date few companies have been (Table 1) . Another company, Bioforce (www.bioforce.co.nz), specialises in predators and parasitoids, but also sells some insecticidal nematodes and a new company, Ecolibrium Ltd was recently registered and intends to produce biopesticides. Several other companies specialise in importation of microbial biopesticides (Table 1) .
New Zealand agriculture has traditionally been strongly reliant on use of synthetic pesticides but as pesticides are de-registered overseas, they are becoming unavailable to New Zealand growers and companies are being forced to source alternatives. Biopesticide registrations are finally increasing in New Zealand in response to this need. Growth in the biopesticide market, both through development of local products and increased importation of products from overseas, is expected to increase as New Zealand growers press for alternative solutions for pest problems. Progress will come through direction of effort and resources to several key areas.
Exciting new opportunities are presented by tapping into New Zealand's unique and relatively under-explored soil and insect-associated microbiota. The potential of further biodiscovery efforts is illustrated by the prior identification of two new insecticidal bacteria (Serratia entomophila and Yersinia entomophaga) from a single endemic scarab pest. Not only were new species described, but their insecticidal toxins (Busby et al. 2013 ) and toxin delivery systems (Heymann et al. 2013 ) also proved to be novel. Further biodiscovery research is warranted and should be fast-tracked to expedite the development of additional novel microorganisms and transfer to industry. Microorganisms with novel modes of action, combinations of agents and new formulations and delivery systems are all areas being explored to bring the next generation of biopesticides to market in New Zealand.
Biopesticides with wider host range (and hence larger markets) are required to replace synthetics in mainstream agriculture. Cost of goods is another key issue under consideration during biopesticide development, as some agents are known to be effective but cannot be produced cheaply. As outlined in Glare et al. (2012) , the desired characteristics of biopesticides include shelf life at room temperature for over 12 months, persistence in the phylloplane for 3 weeks for foliar applied products and compatibility with current farming practice. Some examples of promising new agents under development are briefly discussed below.
Yersinia entomophaga
The bacterium Y. entomophaga (Yersiniaceae) was discovered in New Zealand in the 1990s (Hurst et al. 2011a ) and has considerable potential as a biopesticide as it is active against a reasonably wide range of pests including Lepidoptera, Coleoptera and Orthoptera.
Insecticidal activity is through oral ingestion, followed by deterioration and loss of peritrophic membrane in mid-gut that allows the bacteria to enter the haemocoel, and death follows rapidly (Hurst et al., 2011b (Hurst et al., , 2014 Marshall et al., 2012) . The bacterium can kill in only a few days, making it an effective control agent if it can be applied or delivered to the target insect pest. Several delivery systems are being evaluated including incorporation into baits for controlling caterpillars (Brownbridge et al. 2008) and sprays for foliar feeding pests . The bacterium is safe for a wide range of non-target species including earthworms and bees and has no activity against small mammals, birds or fish.
Brevibacillus laterosporus
Local strains of the insecticidal bacterium Brevibacillus laterosporus are under development as the active agent in New Zealand-developed products (van Zijll de Jong et al. 2016) . B.
laterosporus has been described from many countries and is active against a number of insect species, including Coleoptera, Lepidoptera and Diptera (Ruiu 2013) . Strains of this species were isolated from seeds of brassica and found to be active against insects, including diamondback moth larvae, Plutella xylostella (van Zijll de Jong et al. 2016) . The toxin profiles of the New Zealand strains differed from those overseas (T. Glare and M. Ormskirk, unpubl. data) and, given the potential value, research is underway to develop a commercial product through a local company. An issue hindering commercial development is that the cause of toxicity to insects is not fully understood. As discussed above, importation and development of exotic strains can be problematic, so substituting locally isolated strains of insect pathogens is useful approach to develop biopesticides for New Zealand.
Phasmarhabditis hermaphrodita
Issues with the importation and implementation of biopesticides developed outside of New Zealand are illustrated by recent experiences with the nematode Phasmarhabditis hermaphrodita which has been sold as biological molluscicide in Europe since 1994 (De Ley et al. 2014 ). Slugs are a major issue in cropping in New Zealand, so importation of the product from the Northern Hemisphere has been investigated. However, there were no published records of the nematode in New Zealand so a nationwide sampling survey of endemic slug populations was required. The survey found the nematode at three sites throughout New Zealand (Wilson et al. 2016 ) meaning this it is possible to import the product. However, the small market size has not yet attracted company interest in funding the registration process, when larger markets such as California are being explored. To be clear, under the current guidelines nematodes are required to be registered but not as microbials.
Recommendations for increasing adoption of biopesticides in New Zealand
Focus on strategic pest issues
Focus needs to be placed on identifying microorganisms in New Zealand that target both New Zealand's key insect pests and economically significant global pests. This would take advantage of the often unique microbial pathogens found in New Zealand, and as the targets are sufficiently large international markets have a higher chance of attracting investment for research and development. Biopesticides could be developed in cooperation with multinational companies with more resources and expertise in development and registration in other jurisdictions. This approach is not necessarily straightforward as each jurisdiction needs to ensure that exotic microorganisms (from New Zealand) pose no issues in terms of environmental safety. In the future, metagenomics techniques may provide sufficient evidence that microorganisms of interest have a cosmopolitan distribution and this would help to reduce barriers to importation.
Streamline regulatory environment
Further changes to regulatory procedures, such as streamlining testing for the specific nature of each biopesticide, and additional resources to ease the progression of new biopesticides through the registration process would be very advantageous. In some jurisdictions, there are strong Government directives which incentivise industry to focus on development of biopesticides as opposed to synthetic pesticides, in part through simplification and cost reduction in biopesticide registration. New Zealand has recently made a good start in issuing specific guidelines for microbial-based products (as described above), but cost will remain an issue for development of products for small markets. With a relatively small research community, there is also a lack of specialists to evaluate new products, which can delay the process and lead to unnecessary costs.
Use proven organisational models for commercial development and uptake
Driven by the need to meet minimum residue limits on export products, New Zealand has a history of development of successful IPM programmes that are underpinned by biopesticides and biological control, such as in apples and kiwifruit. A key factor in the success of these programmes has been the effectiveness of industry bodies such as Zespri, a levy-funded organisation that funds research that underpins the competitive advantage of the kiwifruit sector and is involved in evaluation of new products, including biopesticides.
Products with demonstrated efficacy are endorsed by Zespri and the organisation works closely with growers to achieve best practice in kiwifruit production, including educating growers about implementation of new products. Such industry organisations have a key role in increasing the development and uptake of biopesticides into mainstream agriculture, especially in a small economy country such as New Zealand.
Historically, biopesticide research and development has been undertaken within Universities and research organisations, rather than by industry. More recently there has been a move to partner early with companies with required expertise in scale-up of production and formulation and full commercialisation. Partnering early with companies is a useful strategy for researchers in New Zealand, where research and development funding is limited.
Invest in infrastructure
Some strategic investment in infrastructure may also be required. There is currently limited capacity for large scale production of microbial biomass in New Zealand, which has hampered product development. There has been interest for a number of years in investment in production facilities, but few advancements. A recommendation is that such infrastructure is developed, which may require direct government investment.
Conclusions
New approaches, such as trait-led biodiscovery, novel formulations and the use of genomic tools to find useful strains, are leading to new products with potential international applications. The launch of several new start-up companies suggests a brighter future for biopesticide use in New Zealand. The issue of small market size can be addressed through international partnerships or special registration assistance programmes and government co-development investment. The very strong drivers for the move away from synthetic pesticide use to more sustainable production systems to maintain market access for New Zealand's exports are expected to lead to further investment in the biopesticide industry.
